This New Drug Could Help End the HIV Epidemic—but US Funding Cuts Are Killing Its Rollout
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under threat.
Lenacapavir, a twice yearly injection that prevents HIV transmission, was named the breakthrough medicine of 2024. But without US foreign aid dollars, its delivery to millions worldwide is under threat.
What's Your Reaction?
Hemanth Kumar Gorle
Mr. Hemanth Kumar Gorle, founder of Indian Web Services, specializes in web development, hosting, and online marketing. He is dedicated to creating effective digital solutions and fostering successful business relationships through his expertise and strategic approach.
